Published in J Clin Invest on September 01, 1985
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med (1993) 1.61
Multiple myeloma cancer stem cells. J Clin Oncol (2008) 1.39
Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med (1989) 1.32
The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow. Br J Cancer (1987) 1.21
Cancer stem cells: controversies in multiple myeloma. J Mol Med (Berl) (2009) 1.15
Ras oncogene mutation in multiple myeloma. J Exp Med (1989) 1.11
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. Clin Exp Immunol (1987) 1.06
Cancer stem cells in multiple myeloma. Cancer Lett (2008) 1.06
Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J Exp Med (1994) 1.03
Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol (1991) 0.98
Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells. Br J Cancer (2009) 0.98
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. J Exp Med (1993) 0.91
Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern. J Clin Invest (1987) 0.90
A prognostic index for multiple myeloma. Br J Cancer (1996) 0.90
Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. J Clin Invest (1989) 0.86
An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens. Clin Exp Immunol (1988) 0.86
Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1). J Clin Pathol (1998) 0.78
Selective induction of light chain synthesis in cultures of blood lymphocytes from patients with IgG myelomatosis. Clin Exp Immunol (1988) 0.75
The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice. Mediators Inflamm (2014) 0.75
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer (1975) 10.04
Characterization of a human B lymphocyte-specific antigen. J Immunol (1980) 5.76
A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature (1980) 3.90
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol (1983) 3.09
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91
Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J Natl Cancer Inst (1978) 2.66
Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol (1979) 2.53
A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol (1981) 2.52
Primary bioassay of human myeloma stem cells. J Clin Invest (1977) 2.25
Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia. N Engl J Med (1978) 2.05
P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med (1981) 1.79
Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol (1978) 1.76
Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation. Immunol Rev (1979) 1.64
Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood (1983) 1.54
B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest (1984) 1.51
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia. Lancet (1976) 1.38
Induction of differentiation in a case of common acute lymphoblastic leukemia. N Engl J Med (1982) 1.29
Normal equivalent cells of B cell malignancies: analysis with monoclonal antibodies. Br J Haematol (1983) 1.29
The growth fraction of human myeloma cells. Blood (1981) 1.24
Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. J Clin Invest (1982) 1.21
Aggressive plasma cell myeloma. A terminal phase. Arch Intern Med (1981) 1.17
Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood (1984) 1.17
Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia. Leuk Res (1979) 1.16
An immunohistologic study of multiple myeloma and related conditions, using an immunoperoxidase method. Am J Clin Pathol (1978) 1.12
Immunoenzymatic staining of haematological samples with monoclonal antibodies. Br J Haematol (1983) 1.09
Acute lymphoblastic leukemia with pre-B-cell characteristics. Blood (1979) 1.09
VIL-A1, a monoclonal antibody reactive with common acute lymphatic leukemia cells. Leuk Res (1982) 1.08
Plasmacytic reticulum cell sarcoma. Case report with electron microscopic studies. Am J Clin Pathol (1966) 1.06
Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol (1984) 1.03
The changing face of myeloma. Lancet (1966) 1.02
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood (1984) 0.96
Multiple myeloma: development of plasma cell sarcoma during apparently successful chemotherapy. J Clin Pathol (1973) 0.95
Monitoring myelomatosis. Arch Intern Med (1975) 0.92
The ontogeny of terminal deoxynucleotidyl transferase positive cells in the human fetus. Blood (1983) 0.90
Aggressive phase of multiple myeloma with pulmonary cell infiltrates. JAMA (1982) 0.89
Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res (1984) 0.88
Circulating tumor cells in murine myeloma. J Natl Cancer Inst (1977) 0.87
Philadelphia chromosome in human multiple myeloma. J Natl Cancer Inst (1979) 0.87
Human myeloma cell line carrying a Philadelphia chromosome. Science (1982) 0.86
Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. Clin Exp Immunol (1984) 0.81
Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: a clinicopathologic study of 10 cases. Blood (1982) 0.80
Decreasing M spike with increasing tumor burden in multiple myeloma. Arch Intern Med (1981) 0.77
In vivo kinetic studies in human myeloma. Haematologica (1974) 0.77
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol (1988) 7.37
Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet (1981) 6.62
Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol (1971) 6.43
Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant Rev (1972) 5.10
Functional analysis of murine and human B lymphocyte subsets. Transplant Rev (1975) 3.69
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia (2004) 3.59
Serial CD4 lymphocyte counts and development of AIDS. Lancet (1991) 3.42
Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med (1974) 3.39
Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med (1982) 3.25
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17
Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol (1986) 3.11
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet (1998) 3.07
An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol (1982) 3.05
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia (2007) 2.96
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood (2000) 2.92
Diffuse panbronchiolitis. Eur Respir J (2006) 2.91
Intracellular cytokine profile of cord and adult blood lymphocytes. Blood (1998) 2.90
Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Lancet (1995) 2.90
Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol (1982) 2.86
Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut (1984) 2.74
Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors". Eur J Immunol (1982) 2.72
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. Clin Exp Immunol (1981) 2.68
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67
Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J Natl Cancer Inst (1978) 2.66
Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol (1979) 2.53
The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med (1993) 2.50
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41
Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract. Gut (1981) 2.38
Lymphocyte activation. II. discriminating stimulation of lymphocyte subpopulations by phytomitogens and heterologous antilymphocyte sera. Clin Exp Immunol (1972) 2.37
Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. Clin Exp Immunol (1983) 2.34
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia (2009) 2.24
Human T lymphocytes of inducer and suppressor type occupy different microenvironments. Nature (1980) 2.23
Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J (1995) 2.23
Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J (2003) 2.15
Lymphocyte activation. 3. Binding sites for phytomitogens on lymphocyte subpopulations. Clin Exp Immunol (1972) 2.14
The synergy between naive and memory T cells during activation. Immunol Today (1991) 2.13
Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med (1996) 2.10
Differential diagnosis of malignant lymphoma and nonlymphoid tumors using monoclonal anti-leucocyte antibody. Cancer (1980) 2.05
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol (2012) 2.03
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01
Distribution of t lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies. J Immunol (1981) 2.00
Mite-antigen avoidance can reduce bronchial epithelial shedding in allergic asthmatic children. Clin Exp Allergy (1998) 2.00
A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum (1985) 1.99
T-cell regulation of immunoglobulin synthesis and proliferation in pokeweed (Pa-1)-stimulated human lymphocyte cultures. Scand J Immunol (1977) 1.97
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia (2000) 1.94
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res (1999) 1.90
Patterns of gene expression and the cellular origins of human leukaemias. Biochim Biophys Acta (1978) 1.89
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia (2004) 1.87
Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. BMJ (1994) 1.87
IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J Immunol (1998) 1.85
Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol (1981) 1.83
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia (1999) 1.83
A multicenter international study on the Spinal Cord Independence Measure, version III: Rasch psychometric validation. Spinal Cord (2006) 1.80
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood (2001) 1.79
Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J Pathol (2001) 1.78
Delineation of human thymocyte differentiation pathways utilizing double-staining techniques with monoclonal antibodies. Clin Exp Immunol (1981) 1.78
HIV seroprevalence in a London same-day testing clinic. AIDS (1994) 1.78
Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol (1982) 1.76
Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining. Clin Exp Immunol (1982) 1.75
Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol (2001) 1.74
Large mononuclear (veiled) cells like 'Ia-like' membrane antigens in human afferent lympn. Clin Exp Immunol (1980) 1.74
CD30 and type 2 T helper (Th2) responses. J Leukoc Biol (1995) 1.72
Separate ontogeny of two macrophage-like accessory cell populations in the human fetus. J Immunol (1986) 1.71
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol (1994) 1.67
Human B cell development. II. Subpopulations in the human fetus. J Immunol (1985) 1.67
Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (2004) 1.65
Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS (1996) 1.64
An essential role for BLNK in human B cell development. Science (1999) 1.64
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol (1985) 1.64
Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann Rheum Dis (1983) 1.64
Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry (2000) 1.63
Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet (1980) 1.61
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res (1985) 1.61
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Acid esterase in human lymphoid cells and leukaemic blasts: a marker for T lymphocytes. Br J Haematol (1977) 1.59
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59
Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS (1997) 1.58
Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol (2004) 1.57
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol (1998) 1.56
Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis. Thorax (2007) 1.56
The effects of purified mitogenic proteins (Pa-1 and Pa-2) from pokeweed on human T and B lymphocytes in vitro. Clin Exp Immunol (1976) 1.56
The involvement of interdigitating (antigen-presenting) cells in the pathogenesis of rheumatoid arthritis. Clin Exp Immunol (1983) 1.56
Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med (1998) 1.55
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation. Leukemia (1994) 1.54
The role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung diseases: pro. Rev Port Pneumol (2011) 1.54